RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...
Illumina stock recovered early losses Tuesday after China signaled it would ban the company from importing its gene-mapping ...
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...
Illumina (NASDAQ:ILMN – Free Report) had its price target cut by Citigroup from $130.00 to $90.00 in a research note released on Tuesday, Marketbeat reports.They currently have a neutral rating ...
11 analysts have expressed a variety of opinions on Illumina ILMN over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...
Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...
Morgan Stanley decreased their price target on shares of Illumina from $150.00 to $136.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 11th.
Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...
In this article, we are going to take a look at where Illumina Inc. (NASDAQ:ILMN) stands against the other stocks. Wall Street's major indices kicked off the trading on a positive note ...